News
Current state of health research on poverty-related diseases in sub-Saharan Africa
Today, the European & Developing Countries Clinical Trials Partnership (EDCTP), RAND Europe and Baird’s CMC have published a report on the current state of health…
REMoxTB trial results confirm moxifloxacin safety but not shortened tuberculosis treatment
Prof. Charles Mgone, EDCTP Executive Director: “A shorter treatment regimen would have great significance for individual patients and TB care programmes alike. Unfortunately, this goal…
Launch of the second EDCTP programme against poverty-related diseases in Africa
The high-level event expects to welcome approximately 200 delegates, including African and European government representatives, major research funders, scientists, industry representatives and other experts in…
TAM-TB: New sputum-independent diagnostic tool for tuberculosis in children
Today, The Lancet Infectious Diseases published the results of a sputum-independent assay developed in Tanzania that is able to diagnose active tuberculosis in children. The…
Results of trial to assess second-line therapy in HIV patients in Africa published
The combination of a boosted protease inhibitor (lopinavir) with two nucleoside reverse-transcriptase inhibitors (NRTIs) is a feasible second-line therapy for HIV patients in Africa. These…
EDCTP Annual Report 2013 available online
The interactive EDCTP Annual Report 2013 “The First Decade” is now available on the website. It gives access to the complete Annual Report 2013 in…
International clinical trials day: EDCTP extends its gratitude to all clinical trial volunteers
Clinical trials depend on the participation of volunteers, both the healthy and those suffering from disease. Their dedication based on free and well informed consent…
Dr Pascoal Mocumbi takes his leave as the EDCTP High Representative
With the end of the first programme nearing, Dr Pascoal Mocumbi has taken his leave as the High Representative of the European & Developing Countries…
Historic step: African countries join EDCTP2
Today, eight African and eight European countries have formalised their participation in the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP)…
European Union approves second EDCTP programme
Today, the Council of the European Union in its meeting on Economic and Financial Affairs (ECOFIN) has approved the participation of the European Union in…
World Malaria Day 2014: ‘Invest in the Future. Defeat Malaria’
The second EDCTP programme (EDCTP2) is expected to commence in the second half of 2014. On 15 April, the European Parliament approved the participation of…
European Parliament approves second EDCTP programme
As part of the preparations for the second programme, EDCTP has changed its legal structure for the second programme from European Economic Interest Grouping (EEIG)…
World Tuberculosis Day 2014: Reaching the missing 3 million
The necessity for new and improved diagnostics for TB, as well as the need to evaluate the implementation of diagnostics in real-life settings was emphasised…
HIV clinical trials PROMISE-PEP and 2LADY: results presented at CROI 2014
The PROMISE-PEP study was coordinated by Prof. Philippe Van de Perre (University of Montpellier 1, France). It aimed to evaluate antiretroviral treatment in infants to…
Proceedings of the EDCTP Stakeholder meeting on HIV/AIDS published
The European & Developing Countries Clinical Trials Partnership (EDCTP) published the report of its Stakeholder meeting on HIV/AIDS today. The meeting was held in Lisbon,…